Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Genentech Provides Update on Phase III persevERA Study in ER-positive Advanced Breast Cancer

Summary by Enid News & Eagle
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Mar 9, 2026-

3 Articles

Hastings TribuneHastings Tribune
Reposted by
Enid News & EagleEnid News & Eagle
Center

Genentech Provides Update on Phase III persevERA Study in ER-positive Advanced Breast Cancer

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Mar 9, 2026-

·Nebraska, United States
Read Full Article
stocktitan.netstocktitan.net

Breast cancer drug giredestrant falls short in trial, still heads to FDA

Phase III persevERA testing giredestrant plus palbociclib missed its PFS goal, even as FDA reviews evERA data and lidERA results head for submission.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources lean Left, 50% of the sources are Center
50% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

stocktitan.net broke the news in on Monday, March 9, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

South San Francisco icon

South San Francisco

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal